Michael Gelband’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-54,102
Closed -$21.4M 2007
2025
Q2
$21.4M Buy
+54,102
New +$20.2M 0.19% 107
2022
Q3
Sell
-37,263
Closed -$7.41M 2289
2022
Q2
$7.41M Buy
+37,263
New +$8.75M 0.09% 274
2022
Q1
Sell
-4,541
Closed -$1.21M 2669
2021
Q4
$1.21M Sell
4,541
-4,799
-51% -$1.26M 0.01% 965
2021
Q3
$2.46M Buy
+9,340
New +$2.5M 0.03% 643
2021
Q2
Sell
-8,726
Closed -$2.13M 2787
2021
Q1
$2.13M Buy
8,726
+3,669
+73% +$880K 0.03% 550
2020
Q4
$1.24M Sell
5,057
-28,183
-85% -$6.38M 0.01% 749
2020
Q3
$6.93M Buy
33,240
+16,313
+96% +$3.17M 0.14% 134
2020
Q2
$3.05M Buy
16,927
+3,394
+25% +$626K 0.08% 288
2020
Q1
$2.25M Buy
+13,533
New +$2.64M 0.12% 164
2019
Q4
Sell
-1,400
Closed -$303K 1869
2019
Q3
$303K Buy
+1,400
New +$300K 0.01% 871
2019
Q1
Sell
-3,299
Closed -$517K 766
2018
Q4
$517K Buy
+3,299
New +$552K 0.04% 141

Other funds holding SYK

Michael Gelband's SYK Position: Q3 2025 in Review

Michael Gelband sold out of Stryker (SYK) in Q3 2025, closing a stake of 54,102 shares — an estimated $21.4M sold.

Michael Gelband first reported a position in SYK in Q4 2018 and held it in 11 quarters. The position peaked at $21.4M in Q2 2025. 2,272 funds tracked by Wall St. Rank hold SYK as of Q3 2025.

  • Michael Gelband reported no remaining Stryker position as of Q3 2025 after selling out during the quarter.
  • Michael Gelband sold 54,102 Stryker shares in Q3 2025, an estimated $21.4M.
  • Michael Gelband first reported a position in Stryker in Q4 2018 and held it in 11 quarters.
  • Michael Gelband's Stryker position peaked at $21.4M in Q2 2025.
  • 2,272 funds tracked by Wall St. Rank held Stryker as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.